Handelsbanken Fonder’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $577K | Sell |
18,316
-800
| -4% | -$25.2K | ﹤0.01% | 1189 |
|
|
2025
Q1 | $626K | Hold |
19,116
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q4 | $691K | Buy |
19,116
+1,900
| +11% | +$68.7K | ﹤0.01% | 1158 |
|
|
2024
Q3 | $537K | Hold |
17,216
| – | – | ﹤0.01% | 1210 |
|
|
2024
Q2 | $461K | Buy |
17,216
+4,800
| +39% | +$129K | ﹤0.01% | 1193 |
|
|
2024
Q1 | $424K | Hold |
12,416
| – | – | ﹤0.01% | 1236 |
|
|
2023
Q4 | $359K | Hold |
12,416
| – | – | ﹤0.01% | 1311 |
|
|
2023
Q3 | $342K | Hold |
12,416
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q2 | $373K | Hold |
12,416
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q1 | $450K | Hold |
12,416
| – | – | ﹤0.01% | 1046 |
|
|
2022
Q4 | $443K | Hold |
12,416
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q3 | $420K | Hold |
12,416
| – | – | ﹤0.01% | 1065 |
|
|
2022
Q2 | $359K | Hold |
12,416
| – | – | ﹤0.01% | 1222 |
|
|
2022
Q1 | $401K | Sell |
12,416
-4,200
| -25% | -$136K | ﹤0.01% | 1356 |
|
|
2021
Q4 | $485K | Hold |
16,616
| – | – | ﹤0.01% | 1373 |
|
|
2021
Q3 | $443K | Hold |
16,616
| – | – | ﹤0.01% | 1428 |
|
|
2021
Q2 | $512K | Buy |
16,616
+6,600
| +66% | +$203K | ﹤0.01% | 1363 |
|
|
2021
Q1 | $262K | Hold |
10,016
| – | – | ﹤0.01% | 1485 |
|
|
2020
Q4 | $252K | Hold |
10,016
| – | – | ﹤0.01% | 1465 |
|
|
2020
Q3 | $209K | Hold |
10,016
| – | – | ﹤0.01% | 1379 |
|
|
2020
Q2 | $238K | Buy |
+10,016
| New | +$238K | ﹤0.01% | 1318 |
|